Hemiplegic Migraine After Triptan Monotherapy Has Not Achieved Pain Freedom

This protocol is for hemiplegic migraine attacks where initial triptan treatment has not produced pain freedom at two hours after intake — the threshold that defines an adequate response. When that goal is not met, a structured next-line approach is indicated.

Previous Treatment — Insufficient Response

The prior line used a triptan (a 5-HT1B/1D agonist) for moderate-to-severe hemiplegic migraine attacks, administered after the aura had abated. The defined goal — freedom from pain two hours after intake — was not achieved, making escalation to this protocol appropriate.

Next-Step Treatment Approach

When triptan monotherapy is insufficient, this protocol moves to combination therapy. The approach involves pairing a triptan with a long-acting NSAID. The complete regimen — including agent selection, timing, and management of headache recurrence — is detailed in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1177/2514183X1882337

The combination of triptans with naproxen is more effective than monotherapy.
In unsatisfactory effectiveness of a triptan, the triptan may be combined with a rapid-acting NSAID.
The initial combination of a triptan with a long-acting NSAID (such as naproxen) is more effective than the individual components and can in part prevent the recurrence of migraine attacks.

View source ↗